Results 31 to 40 of about 29,238 (215)

CONVENTIONAL METHODS FOR THE DIAGNOSIS OF PNEUMOCYSTIS JIROVECII IN IMMUNOCOMPROMISED IRAQI PATIENTS

open access: yesThe Iraqi Journal of Medical Sciences, 2016
Background: Pneumocystis jirovecii is the causative agent of pneumocystis pneumonia, one of the most frequent and severe opportunistic infections in immunocompromised patients.
Isa S. Touhali   +2 more
doaj   +6 more sources

Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report

open access: yesAllergy, Asthma & Clinical Immunology, 2022
Background Biologics dramatically improve symptoms of severe asthma; however, various exacerbating factors may induce flare-up. Pneumocystis spp. have not been reported as a cause of asthma exacerbation during biologic use, although patients with severe ...
Kazuya Takeda   +7 more
doaj   +1 more source

Successful Treatment of Pulmonary and Cerebral Toxoplasmosis Associated with Pneumocystis Pneumonia in an HIV Patient

open access: yesDiseases, 2017
In both the post and pre combination antiretroviral therapy (cART) era, Pneumocystis jirovecii and Toxoplasma gondii remain common opportunistic infectious agents. The common manifestations are pneumonia for P. jirovecii and brain abscess for T.
Marie-Françoise Rey   +5 more
doaj   +1 more source

Absolute lymphocyte count as a predictor of Pneumocystis pneumonia in patients previously unknown to have HIV [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2012
This is a retrospective review of patients admitted to an inner city community hospital with community-acquired pneumonia who were ultimately diagnosed with AIDS and Pneumocystis. Absolute lymphocyte count in our hospital is available immediately.
Robert P. Ferguson, Aghogho A. Omene
doaj   +1 more source

Pneumonia por Pneumocystis em 107 Doentes com Infecção por VIH Internados no Serviço de Doenças Infecciosas, Hospital de Santa Maria, Lisboa (2002 - 2013)

open access: yesActa Médica Portuguesa, 2016
Introdução: A pneumonia por Pneumocystis jirovecii é das doenças infecciosas oportunistas mais comuns em infectados por vírus da imunodeficiência humana, sendo, actualmente, em Portugal a infecção definidora de sida mais reportada.
Vilma Grilo, Aida Pereira
doaj   +1 more source

A case of Talaromyces marneffei infection that required differentiation from Pneumocystis pneumonia

open access: yesIDCases, 2023
We report a case of Talaromyces marneffei fungemia in a patient with HIV infection with a history of travelling to southern China. At first, Pneumocystis pneumonia was considered in this case because chest CT images showed typical ground-glass opacity ...
Mieko Tokano   +8 more
doaj   +1 more source

Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan   +8 more
doaj   +1 more source

Genotypic variation in Pneumocystis jirovecii isolates in Britain

open access: yes, 2005
Background: Pneumocystis jirovecii is the cause of Pneumocystis pneumonia (PCP) in immunosuppressed humans. Asymptomatic colonisation with P jirovecii may occur in patients with minor immunosuppression or chronic lung disease.
Davies, RJ   +6 more
core   +1 more source

Fatal sepsis in an AIDS patient during therapy for Pneumocystis carinii pneumonia [PDF]

open access: yes, 2002
The case of a patient with a newly diagnosed HIV infection and Pneumocystis carinii pneumonia is presented. Despite treatment with high-dose trimethoprim/sulfamethoxazole (TMP/SMX) and prednisone with initial improvement, the patient acutely deteriorated
Täuber, MG   +4 more
core   +1 more source

Bendamustine and pneumocystis pneumonia: A systematic review

open access: yes, 2022
BACKGROUND: Bendamustine, a bifunctional mechlorethamine alkylating agent, is used in the treatment of patients with hematologic malignancies. Myelosuppression and cytotoxic effect arises quite often after bendamustine treatment. To date, there have been
Gholipur‐Shahraki, Tahereh   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy